These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17460341)

  • 1. [New drug treatment for age-related macular degeneration].
    Stefánsson E; la Cour M; Helgadóttir G; Sigurdsson H; Jónasson F
    Laeknabladid; 2007 Apr; 93(4):299-301. PubMed ID: 17460341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the treatment of wet age-related macular degeneration.
    Moreno SF; Paloma JB
    Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 4. Charles Bonnet syndrome (visual hallucinations) after intravitreal avastin injection for age-related macular degeneration.
    Tan CS; Sanjay S; Au Eong KG
    Am J Ophthalmol; 2007 Aug; 144(2):330; author reply 330-1. PubMed ID: 17659977
    [No Abstract]   [Full Text] [Related]  

  • 5. Microperimetric changes after intravitreal bevacizumab for exudative age-related macular degeneration.
    Rensch F; Jonas JB
    Acta Ophthalmol; 2008 Sep; 86(6):696-7. PubMed ID: 18752522
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study of bevacizumab vs ranibizumab for age-related macular degeneration: inappropriate conclusions.
    Messori A; Fadda V; Trippoli S
    Am J Ophthalmol; 2010 May; 149(5):867; author reply 867. PubMed ID: 20399931
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal avastin: the low cost alternative to lucentis?
    Rosenfeld PJ
    Am J Ophthalmol; 2006 Jul; 142(1):141-3. PubMed ID: 16815262
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F; Eid Farah M; Melo GB
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract]   [Full Text] [Related]  

  • 9. Tachyphylaxis and bevacizumab.
    Ziemssen F; Neuhann IM; Voelker M
    Ophthalmology; 2009 Aug; 116(8):1591-2; author reply 1592-3. PubMed ID: 19651319
    [No Abstract]   [Full Text] [Related]  

  • 10. Tachyphylaxis and bevacizumab.
    Avgikos KN; Horgan SE; Sivaraj RR; Hu K
    Ophthalmology; 2009 Sep; 116(9):1831-2; author reply 1832. PubMed ID: 19729101
    [No Abstract]   [Full Text] [Related]  

  • 11. Bevacizumab tachyphylaxis.
    Falavarjani KG; Modarres M
    Ophthalmology; 2009 May; 116(5):1016-7; author reply 1017. PubMed ID: 19410964
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?
    Bopp S
    Br J Ophthalmol; 2007 Oct; 91(10):1259-60. PubMed ID: 17895411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of exudative age-related macular degeneration: many factors to consider.
    Olsen TW
    Am J Ophthalmol; 2007 Aug; 144(2):281-3. PubMed ID: 17659955
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of neovascular age-related macular degeneration with bevacizumab].
    Monzón Moreno A
    Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
    [No Abstract]   [Full Text] [Related]  

  • 15. Avastin and new treatments for AMD: where are we?
    Freeman WR; Falkenstein I
    Retina; 2006 Oct; 26(8):853-8. PubMed ID: 17031283
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?
    la Cour M
    Acta Ophthalmol Scand; 2007 Feb; 85(1):2-4. PubMed ID: 17244202
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation therapy for neovascular age-related macular degeneration revisited.
    Kim IK; Gragoudas ES
    Br J Ophthalmol; 2009 Mar; 93(3):279-80. PubMed ID: 19244026
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin).
    Utman SA; Dhillon B
    Retina; 2008 Apr; 28(4):667; author reply 667-8. PubMed ID: 18398378
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.
    Donahue SP; Recchia F; Sternberg P
    Am J Ophthalmol; 2010 Aug; 150(2):287; author reply 287. PubMed ID: 20670740
    [No Abstract]   [Full Text] [Related]  

  • 20. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.
    Spaide RF
    Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.